Published in Endocr Relat Cancer on January 27, 2016
25-Hydroxyvitamin D and TSH as Risk Factors or Prognostic Markers in Thyroid Carcinoma. PLoS One (2016) 0.75
Function of the vitamin D endocrine system in mammary gland and breast cancer. Mol Cell Endocrinol (2017) 0.75
RIPK1 binds to vitamin D receptor and decreases vitamin D-induced growth suppression. J Steroid Biochem Mol Biol (2017) 0.75
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia (1985) 109.13
Health and economic burden of the projected obesity trends in the USA and the UK. Lancet (2011) 10.73
Adipokines in inflammation and metabolic disease. Nat Rev Immunol (2011) 8.92
Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer (2007) 6.18
Determination of vitamin D status by radioimmunoassay with an 125I-labeled tracer. Clin Chem (1993) 3.87
Aromatase--a brief overview. Annu Rev Physiol (2002) 2.49
The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer (2014) 2.41
Low circulating vitamin D in obesity. Calcif Tissue Int (1988) 2.23
Adiposity, adult weight change, and postmenopausal breast cancer risk. Arch Intern Med (2007) 2.23
AMPK as a metabolic tumor suppressor: control of metabolism and cell growth. Future Oncol (2010) 2.11
Mechanisms of the anti-cancer and anti-inflammatory actions of vitamin D. Annu Rev Pharmacol Toxicol (2011) 1.97
Energy balance, host-related factors, and cancer progression. J Clin Oncol (2010) 1.85
Quantification of circulating 1,25-dihydroxyvitamin D by radioimmunoassay with 125I-labeled tracer. Clin Chem (1996) 1.76
Cytokines, obesity, and cancer: new insights on mechanisms linking obesity to cancer risk and progression. Annu Rev Med (2012) 1.70
Molecular pathways: adipose inflammation as a mediator of obesity-associated cancer. Clin Cancer Res (2013) 1.65
A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription. J Clin Endocrinol Metab (1993) 1.60
Obesity accelerates mouse mammary tumor growth in the absence of ovarian hormones. Nutr Cancer (2008) 1.49
Obesity and breast cancer: status of leptin and adiponectin in pathological processes. Cancer Metastasis Rev (2010) 1.40
1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells. Clin Cancer Res (2000) 1.39
Cellular and molecular effects of vitamin D on carcinogenesis. Arch Biochem Biophys (2011) 1.28
Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells. Cancer Res (2005) 1.27
Tissue-selective regulation of aromatase expression by calcitriol: implications for breast cancer therapy. Endocrinology (2009) 1.19
Comparative effects of 1,25(OH)2D3 and EB1089 on cell cycle kinetics and apoptosis in MCF-7 breast cancer cells. Breast Cancer Res Treat (1997) 1.18
Obesity and breast cancer: progress to understanding the relationship. Cancer Res (2009) 1.14
Obesity and cancer: local and systemic mechanisms. Annu Rev Med (2015) 1.09
Two mutations identified in the androgen receptor of the new human prostate cancer cell line MDA PCa 2a. J Urol (1999) 1.08
Minireview: Obesity and breast cancer: a tale of inflammation and dysregulated metabolism. Mol Endocrinol (2013) 1.08
Adipose tissue as target organ in the treatment of hormone-dependent breast cancer: new therapeutic perspectives. Obes Rev (2009) 1.06
Metformin inhibits aromatase expression in human breast adipose stromal cells via stimulation of AMP-activated protein kinase. Breast Cancer Res Treat (2010) 1.04
Vitamin D and diabetes. Endocrinol Metab Clin North Am (2013) 1.03
Subcellular localization of cyclic AMP-responsive element binding protein-regulated transcription coactivator 2 provides a link between obesity and breast cancer in postmenopausal women. Cancer Res (2009) 1.03
Dietary vitamin D₃ and 1,25-dihydroxyvitamin D₃ (calcitriol) exhibit equivalent anticancer activity in mouse xenograft models of breast and prostate cancer. Endocrinology (2012) 1.00
The potential therapeutic benefits of vitamin D in the treatment of estrogen receptor positive breast cancer. Steroids (2012) 0.98
Obesity and cancer: mechanistic insights from transdisciplinary studies. Endocr Relat Cancer (2015) 0.96
Genomic actions of 1,25-dihydroxyvitamin D3 on insulin receptor gene expression, insulin receptor number and insulin activity in the kidney, liver and adipose tissue of streptozotocin-induced diabetic rats. BMC Mol Biol (2008) 0.94
Obesity and breast cancer: role of inflammation and aromatase. J Mol Endocrinol (2013) 0.94
Tamoxifen versus aromatase inhibitors for breast cancer prevention. Clin Cancer Res (2005) 0.94
Leptin produced by obese adipose stromal/stem cells enhances proliferation and metastasis of estrogen receptor positive breast cancers. Breast Cancer Res (2015) 0.92
Vitamin D status and cancer incidence and mortality. Adv Exp Med Biol (2014) 0.87
Inhibitory effects of calcitriol on the growth of MCF-7 breast cancer xenografts in nude mice: selective modulation of aromatase expression in vivo. Horm Cancer (2011) 0.84
Chemoprevention activity of 25-hydroxyvitamin D in the MMTV-PyMT mouse model of breast cancer. Cancer Prev Res (Phila) (2014) 0.84
Estrogen-mediated mechanisms to control the growth and apoptosis of breast cancer cells: a translational research success story. Vitam Horm (2013) 0.83
Serum 25-hydroxyvitamin D levels and metabolic health status in extremely obese individuals. Obesity (Silver Spring) (2014) 0.82
Targeting cancer stem cells in solid tumors by vitamin D. J Steroid Biochem Mol Biol (2014) 0.80
Aromatase overexpression in dysfunctional adipose tissue links obesity to postmenopausal breast cancer. J Steroid Biochem Mol Biol (2015) 0.80
Transrepression of the estrogen receptor promoter by calcitriol in human breast cancer cells via two negative vitamin D response elements. Endocr Relat Cancer (2013) 0.79
Signs of proinflammatory/genotoxic switch (adipogenotoxicosis) in mammary fat of breast cancer patients: role of menopausal status, estrogens and hyperglycemia. Int J Cancer (2007) 0.77